Search
for
Sort by
Research 121–150 of 1000+
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
- Baricitinib for alopecia areata
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Transcriptomic Analysis Provides Molecular Insights into Skin Development in Dezhou Donkey Foals
- COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- Ornithine Decarboxylase Expression Leads to Translocation and Activation of Protein Kinase CK2 in Vivo
- Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children
- Suspected upadacitinib-associated drug hypersensitivity mimicking disease exacerbation in ulcerative colitis
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
- Janus kinase inhibitors for alopecia areata
- 1325 Age-dependent loss of the stemness and antimicrobial defense function of dermal fibroblasts is mediated by TGFbeta
- Learning from nudity: lessons from the nude phenotype
- A protein kinase target of a PDK1 signalling pathway is involved in root hair growth in Arabidopsis
- The PDGF/PDGFR pathway as a drug target
- A preliminary study of differentially expressed genes in expanded skin and normal skin: implications for adult skin regeneration
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Induction of versican by ascorbic acid 2-phosphate in dermal papilla cells
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature